HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jun Li Selected Research

Em18 antigen

10/2018Evaluation of the diagnostic value of the immunoblotting and ELISA tests using recombinant Em18 antigen in human alveolar echinococcosis from Xingjiang China.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jun Li Research Topics

Disease

1075Neoplasms (Cancer)
05/2024 - 01/2002
317Inflammation (Inflammations)
06/2024 - 11/2002
272Infections
05/2024 - 08/2002
223Neoplasm Metastasis (Metastasis)
04/2024 - 11/2004
189Fibrosis (Cirrhosis)
12/2024 - 07/2004
177Hepatocellular Carcinoma (Hepatoma)
04/2024 - 02/2004
144Breast Neoplasms (Breast Cancer)
04/2024 - 01/2005
107Carcinogenesis
04/2024 - 03/2003
97Liver Cirrhosis (Hepatic Cirrhosis)
06/2024 - 05/2006
97Pain (Aches)
04/2024 - 01/2004
74Stomach Neoplasms (Stomach Cancer)
03/2024 - 07/2006
72Colorectal Neoplasms (Colorectal Cancer)
12/2024 - 01/2004
70Hypoxia (Hypoxemia)
05/2024 - 07/2002
65Prostatic Neoplasms (Prostate Cancer)
04/2024 - 06/2007
64Cardiovascular Diseases (Cardiovascular Disease)
05/2024 - 09/2004
64Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2024 - 08/2003
62Ischemia
01/2024 - 08/2003
61Lung Neoplasms (Lung Cancer)
02/2024 - 08/2002
61Type 2 Diabetes Mellitus (MODY)
01/2024 - 03/2008
60Carcinoma (Carcinomatosis)
01/2024 - 01/2003
58Necrosis
04/2024 - 08/2003
57Wounds and Injuries (Trauma)
05/2024 - 09/2004
55Myocardial Infarction
04/2024 - 01/2006
55Glioma (Gliomas)
01/2024 - 08/2008
54Stroke (Strokes)
04/2024 - 07/2004
53Rheumatoid Arthritis
01/2024 - 02/2008
48Sepsis (Septicemia)
04/2024 - 06/2005
48Ovarian Neoplasms (Ovarian Cancer)
10/2023 - 01/2004
46Liver Diseases (Liver Disease)
03/2024 - 12/2008
45Body Weight (Weight, Body)
06/2024 - 07/2002
44Acute Kidney Injury (Acute Renal Failure)
05/2024 - 12/2004
44Hemorrhage
01/2024 - 08/2007
43Chronic Hepatitis B
02/2024 - 12/2006
41Hypertension (High Blood Pressure)
05/2024 - 06/2005
40COVID-19
04/2024 - 01/2020
40Heart Failure
04/2024 - 09/2004
40Melanoma (Melanoma, Malignant)
09/2023 - 06/2008
39Adenocarcinoma
05/2024 - 12/2004
37Liver Neoplasms (Liver Cancer)
04/2024 - 03/2010
37Cognitive Dysfunction
02/2024 - 11/2002
37Obesity
02/2024 - 09/2007
37Infarction (Infarctions)
11/2023 - 04/2005
35Insulin Resistance
04/2024 - 08/2006
34Atherosclerosis
09/2023 - 09/2007
33Reperfusion Injury
12/2023 - 02/2005
32Bacterial Infections (Bacterial Infection)
03/2024 - 12/2008
32Autoimmune Diseases (Autoimmune Disease)
01/2024 - 05/2008
31Thrombosis (Thrombus)
03/2024 - 10/2008
31Pancreatic Neoplasms (Pancreatic Cancer)
01/2024 - 07/2009
30Hepatitis B
12/2024 - 04/2002
30Brain Ischemia (Cerebral Ischemia)
03/2024 - 04/2005

Drug/Important Bio-Agent (IBA)

479Proteins (Proteins, Gene)FDA Link
04/2024 - 01/2002
229Biomarkers (Surrogate Marker)IBA
04/2024 - 12/2007
171CytokinesIBA
06/2024 - 11/2002
162Messenger RNA (mRNA)IBA
12/2024 - 11/2002
162MicroRNAs (MicroRNA)IBA
04/2024 - 07/2010
103Long Noncoding RNAIBA
02/2024 - 02/2011
96RNA (Ribonucleic Acid)IBA
05/2024 - 08/2002
92DNA (Deoxyribonucleic Acid)IBA
12/2023 - 01/2002
81Therapeutic UsesIBA
02/2024 - 01/2004
77EnzymesIBA
01/2024 - 04/2003
72Glucose (Dextrose)FDA LinkGeneric
03/2024 - 08/2003
72CateninsIBA
11/2023 - 01/2012
67CollagenIBA
05/2024 - 11/2002
66LipidsIBA
04/2024 - 07/2003
64Interleukin-6 (Interleukin 6)IBA
03/2024 - 01/2006
59AntigensIBA
02/2024 - 03/2003
54Small Interfering RNA (siRNA)IBA
04/2024 - 02/2006
52Cisplatin (Platino)FDA LinkGeneric
05/2024 - 12/2007
51Antiviral Agents (Antivirals)IBA
08/2023 - 05/2007
50VaccinesIBA
04/2024 - 01/2003
47Anti-Bacterial Agents (Antibiotics)IBA
03/2024 - 04/2008
46Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2024 - 01/2002
46Transcription Factors (Transcription Factor)IBA
11/2023 - 01/2008
45LigandsIBA
01/2024 - 10/2003
44Circular RNAIBA
04/2024 - 01/2018
41Phosphotransferases (Kinase)IBA
01/2024 - 04/2005
41LipopolysaccharidesIBA
01/2024 - 08/2004
41Peptides (Polypeptides)IBA
12/2023 - 06/2002
39Insulin (Novolin)FDA Link
01/2024 - 03/2008
36Reactive Oxygen Species (Oxygen Radicals)IBA
01/2024 - 08/2007
35AntioxidantsIBA
04/2024 - 02/2010
35Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2024 - 01/2004
33CholesterolIBA
05/2024 - 01/2012
33salicylhydroxamic acid (SHAM)IBA
12/2023 - 12/2004
32Indicators and Reagents (Reagents)IBA
03/2024 - 07/2006
31Immunoglobulin G (IgG)IBA
12/2023 - 03/2003
30AntibodiesIBA
05/2024 - 03/2003
30InterferonsIBA
03/2024 - 12/2005
30Retinaldehyde (Retinal)IBA
03/2024 - 03/2011

Therapy/Procedure

513Therapeutics
04/2024 - 09/2004
144Drug Therapy (Chemotherapy)
04/2024 - 08/2002
69Immunotherapy
05/2024 - 09/2008
65Transplantation
05/2024 - 04/2004
52Chinese Traditional Medicine (Traditional Chinese Medicine)
04/2024 - 01/2007
42Hepatectomy
04/2024 - 09/2004
42Radiotherapy
04/2024 - 07/2003
37Ligation
04/2024 - 06/2005
37Aftercare (After-Treatment)
02/2024 - 10/2006
36Liver Transplantation
03/2023 - 04/2002